Android app Apple app link

Sarepta Therapeutics, Inc. (SRPT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$16.57
Day's range
$17.71

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
03/12/2026 Mizuho Securities Uy Ear $31.00 $17.04   81.92%
03/03/2026 Loop Capital Markets Ilya Zubkov $25.00 $15.87   57.53%
03/03/2026 Jefferies Andrew Tsai $30.00 $15.98   87.78%
11/05/2025 Mizuho Securities Uy Ear $26.00 $16.20   60.49%
11/04/2025 Robert W. Baird Brian Skorney $15.00 $24.45   -38.65%
10/30/2025 Piper Sandler Biren Amin $16.00 $23.45   -31.77%
09/09/2025 Leerink Partners Joseph Schwartz $15.00 $17.57   -14.6%
08/15/2025 Deutsche Bank David Hoang $12.00 $20.30   -40.89%
07/22/2025 Barclays Gena Wang $18.00 $13.32   35.14%
07/21/2025 BMO Capital Kostas Biliouris $50.00 $14.08   255.24%
07/18/2025 Leerink Partners Joseph Schwartz $10.00 $14.08   -28.95%
06/17/2025 Wells Fargo Yanan Zhu $75.00 $21.56   247.87%
06/16/2025 Cantor Fitzgerald Kristen Kluska $20.00 $20.94   -4.49%
06/15/2025 BMO Capital Kostas Biliouris $70.00 $36.18   93.48%
11/27/2024 Piper Sandler Biren Amin $182.00 $136.87   32.98%
11/27/2024 Needham Gil Blum $202.00 $136.87   47.59%
11/07/2024 Robert W. Baird Brian Skorney $193.00 $124.95   54.46%
11/07/2024 Cantor Fitzgerald Kristen Kluska $167.00 $124.95   33.65%
10/20/2024 Jefferies Andrew Tsai $165.00 $127.08   29.84%
08/08/2024 Evercore ISI Gavin Clark-Gartner $179.00 $136.40   31.23%
08/08/2024 Piper Sandler Biren Amin $200.00 $140.06   42.8%
08/08/2024 Barclays Gena Wang $203.00 $140.06   44.94%
08/08/2024 RBC Capital Brian Abrahams $181.00 $140.06   29.23%
07/29/2024 RBC Capital Brian Abrahams $182.00 $147.88   23.07%
06/27/2024 BMO Capital Kostas Biliouris $200.00 $154.79   29.21%
06/26/2024 Piper Sandler Biren Amin $205.00 $156.91   30.65%
06/24/2024 Evercore ISI Gavin Clark-Gartner $185.00 $160.72   15.11%
06/24/2024 Mizuho Securities Uy Ear $200.00 $165.13   21.12%
06/21/2024 Robert W. Baird Brian Skorney $200.00 $171.35   16.72%
06/13/2024 Robert W. Baird Brian Skorney $170.00 $124.00   37.1%
06/13/2024 Piper Sandler Biren Amin $157.00 $119.98   30.86%
06/13/2024 Barclays Gena Wang $185.00 $119.98   54.19%
06/07/2024 BMO Capital Kostas Biliouris $170.00 $117.44   44.75%
05/28/2024 RBC Capital Brian Abrahams $142.00 $123.46   15.02%
05/20/2024 RBC Capital Brian Abrahams $157.00 $130.70   20.12%
05/17/2024 Mizuho Securities Uy Ear $179.00 $132.74   34.85%
05/14/2024 Oppenheimer Hartaj Singh $180.00 $131.70   36.67%
05/06/2024 Morgan Stanley Matthew Harrison $165.00 $135.04   22.19%
05/02/2024 RBC Capital Brian Abrahams $141.00 $130.90   7.72%
03/01/2023 Morgan Stanley Matthew Harrison $187.00 $145.01   28.96%
11/02/2022 Needham Gil Blum $158.00 $105.01   50.46%
03/01/2022 Berenberg Bank Zhiqiang Shu $94.00 $79.56   18.15%
03/01/2022 Needham Gil Blum $150.00 $79.56   88.54%
01/09/2022 Mizuho Securities Uy Ear $160.00 $76.15   110.11%
01/04/2022 BTIG Yun Zhong $125.00 $84.09   48.65%
01/03/2022 Oppenheimer Hartaj Singh $125.00 $89.16   40.2%
10/14/2021 Credit Suisse Judah Frommer $95.00 $84.19   12.84%

Sarepta Therapeutics Inc FAQ's

Sarepta Therapeutics Inc has been rated by research analysts at Morgan Stanley, Piper Sandler, Wolfe Research, Evercore ISI, Deutsche Bank, Wedbush in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.